Chief Medical Officer

Chief Operating and Financial Officer

Ex-Lazard Banker’s Insider Tips Reaped $41 Million Haul, US Says

6 people charged in $41M insider trading scheme tied to 2 biotechs

Kyverna Therapeutics, Immunome, Almonty Industries And Other Big Stocks Moving Higher On Monday

Olema Oncology rises 11.7%

Associate Director, Regulatory Affairs CMC

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. As the Associate Director, Regulatory Affairs CMC, you will be responsible for developing and executing CMC regulatory strategies for Olema product(s) in development and post-approval, ensuring alignment with Health Authority requirements globally.

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. As the Associate Director, Regulatory Affairs CMC, you will be responsible for developing and executing the CMC regulatory strategies for Olema product(s) in development and post-approval, ensuring alignment with Health Authority requirements globally.

Chairman of the Board, President and CEO and Head of the Global Oncology Business Unit

Senior Region Business Director - ADC Oncology at Daiichi Sankyo, Inc.

Dosage regimen of an anti-cdh6 antibody-drug conjugate

The Global Triple Combination Therapy Market: Key Drivers, Trends, Growth Opportunities, And Forecast 2025-2034

Pexidartinib risk evaluation and mitigation strategy (rems)

Dosage regimen of mdm2 inhibitor for treating cancers

Associate Director, Regulatory Affairs CMC and Digital Transformation

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies. The Associate Director, Regulatory Affairs CMC and Digital Transformation, is responsible for regulatory CMC activities and driving the organization's transition toward structured CMC data and digital capabilities.

EVP, Research and Development, CMO

Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes

Avadel Pharmaceuticals shareholders approve acquisition by Alkermes

REG - Irish Takeover Panel - Disclosure Table

Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1

Associate Director, CMC Regulatory Affairs

Alkermes is a fully-integrated, global biopharmaceutical company committed to developing medicines for complex psychiatric and neurological disorders. They are seeking an experienced Associate Director of Regulatory Affairs CMC to lead regulatory strategy and manage CMC activities for late-stage small molecule development programs, ensuring compliance with global regulatory standards.

Chief Human Resources Officer

President

JPM26: Revolution Medicines in spotlight as industry gears up for dealmaking spree

Dow Jones Top Company Headlines at 9 PM ET: Trump 'Inclined' to Keep Exxon Out of Venezuela | Allegiant ...

Dow Jones Top Company Headlines at 11 PM ET: Trump 'Inclined' to Keep Exxon Out of Venezuela | Allegiant ...

Dow Jones Top Company Headlines at 1 AM ET: Trump 'Inclined' to Keep Exxon Out of Venezuela | Allegiant ...

Associate Director, CMC Regulatory

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Associate Director, CMC Regulatory will develop and implement regulatory strategies, coordinate submissions, and ensure compliance with global CMC requirements to support the clinical development of the company's pipeline products.

Chief Executive Officer

The biggest biotech funding rounds in December 2025

Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

Dyne Therapeutics Appoints Vikram Karnani to Board of Directors

Dyne Therapeutics, Inc. Announces the Appointment of Vikram Karnani to Its Board of Directors

Associate Director, Regulatory CMC

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The Associate Director, Regulatory CMC is accountable for executing global CMC regulatory strategies for programs in early and late-stage development, partnering with various teams to support clinical registration and manufacturing efforts.

President and CEO

President & CEO

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Financings for Dec. 18, 2025

Immunome falls -7.2%

Immunome up 16% on varegacestat Phase III results in desmoid tumors

Director/Associate Director, Regulatory Affairs CMC

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. They are seeking a Director/Associate Director, Regulatory Affairs CMC, responsible for developing and executing global regulatory CMC strategies and managing key deliverables while ensuring compliance with regulatory requirements.

Chairman of the Board and Chief Executive Officer

Vice President, Global Strategy and Pipeline, Allergan Aesthetics

JPM: AbbVie pays $650m upfront for RemeGen cancer drug

China's RemeGen Jumps by Limit After Granting AbbVie Novel Cancer Drug Rights in Up to USD5.6 Billion Deal

AbbVie punts up to ~$5 billion on RemeGen bispecific antibody

AbbVie reaches deal with Trump administration on drug prices in exchange for tariff relief

AbbVie is dedicated to discovering and delivering innovative medicines and solutions for serious health issues. The Associate Director Regulatory Affairs CMC will work with partners to develop regulatory strategies and manage submissions, ensuring compliance and fostering relationships with regulatory agencies.

Associate Director, Regulatory Affairs CMC - Hybrid Onsite

Chief Executive Officer (Interim) and Director

President, Skin Health & Beauty, North America and EMEA at Kenvue

Kenvue faces class action over Johnson’s baby oil labeling

This Week in Chancery Court: Kimberly-Clark Disclosure, Payscale

JPMorgan M&A global head Aiyengar says rising risks to drive surge in deals

JPMorgan M&A global head says rising risks to drive surge in deals

Associate Director, Regulatory Affairs, CMC

Kenvue is a company dedicated to everyday care and is known for its iconic brands. The Associate Director, Regulatory Affairs CMC, will develop regulatory strategies and guide product development for Kenvue’s Skin Health and Beauty products, ensuring compliance with regulatory submissions and agency meetings.

Associate Director, Regulatory CMC (Small Molecule)

BeOne Medicines is a rapidly growing company focused on fighting cancer, seeking an experienced regulatory professional to manage and complete regulatory projects. The role involves developing strategies, managing CMC-related regulatory submissions, and collaborating with cross-functional teams to ensure compliance with regulatory requirements.

Neuren Pharmaceuticals Says Nasdaq-Listed Partner Receives US FDA Approval for Oral Solution; Shares Up 3%

Acadia Pharmaceuticals Inc. Announces FDA Approval of Daybue®? STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome

ACADIA Pharmaceuticals, Inc. (ACAD) Announces $15 Million Private Placement

Acadia Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operating Overview

Acadia Pharmaceuticals is committed to making a difference for underserved neurological and rare disease communities. The Associate Director, Regulatory CMC, will contribute to the development and implementation of global regulatory CMC strategies, coordinate regulatory activities for clinical trials, and interact with global regulatory agencies.

Associate Director, Cmc Regulatory

Associate Director, Cmc Regulatory in united states (1000+)

Associate Director, Regulatory Affairs CMC

Associate Director, Regulatory Affairs CMC

Associate Director, Regulatory Affairs CMC

Associate Director, Regulatory Affairs CMC and Digital Transformation

Associate Director, CMC Regulatory Affairs

Associate Director, CMC Regulatory

Associate Director, Regulatory CMC

Director/Associate Director, Regulatory Affairs CMC

Associate Director, Regulatory Affairs CMC - Hybrid Onsite

Associate Director, Regulatory Affairs, CMC

Associate Director, Regulatory CMC (Small Molecule)

Associate Director, Regulatory Affairs CMC